- Home
- WEAV vs ETON Comparison
WEAV vs ETON Comparison
Compare WEAV & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEAV
- ETON
- Stock Information
- Founded
- WEAV 2011
- ETON 2017
- Country
- WEAV United States
- ETON United States
- Employees
- WEAV N/A
- ETON N/A
- Industry
- WEAV EDP Services
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- WEAV Technology
- ETON Health Care
- Exchange
- WEAV Nasdaq
- ETON Nasdaq
- Market Cap
- WEAV 600.1M
- ETON 498.8M
- IPO Year
- WEAV 2021
- ETON 2018
- Fundamental
- Price
- WEAV $6.43
- ETON $16.63
- Analyst Decision
- WEAV Strong Buy
- ETON Strong Buy
- Analyst Count
- WEAV 5
- ETON 3
- Target Price
- WEAV $12.20
- ETON $29.67
- AVG Volume (30 Days)
- WEAV 1.3M
- ETON 279.7K
- Earning Date
- WEAV 10-30-2025
- ETON 11-06-2025
- Dividend Yield
- WEAV N/A
- ETON N/A
- EPS Growth
- WEAV N/A
- ETON N/A
- EPS
- WEAV N/A
- ETON N/A
- Revenue
- WEAV $229,790,000.00
- ETON $70,316,000.00
- Revenue This Year
- WEAV $19.19
- ETON $105.25
- Revenue Next Year
- WEAV $15.09
- ETON $40.84
- P/E Ratio
- WEAV N/A
- ETON N/A
- Revenue Growth
- WEAV 17.34
- ETON 102.77
- 52 Week Low
- WEAV $6.29
- ETON $8.43
- 52 Week High
- WEAV $17.63
- ETON $23.00
- Technical
- Relative Strength Index (RSI)
- WEAV 42.76
- ETON 35.36
- Support Level
- WEAV $6.41
- ETON $17.49
- Resistance Level
- WEAV $7.51
- ETON $20.03
- Average True Range (ATR)
- WEAV 0.34
- ETON 1.04
- MACD
- WEAV -0.01
- ETON -0.10
- Stochastic Oscillator
- WEAV 11.84
- ETON 7.30
About WEAV Weave Communications Inc.
Weave Communications Inc is a customer experience and payments software platform tailored for SMB healthcare businesses, that revolutionizes patient interaction from initial contact to billing. It integrates diverse workflows into a unified solution, minimizing manual tasks and maximizing patient engagement. Weave democratizes enterprise-level communication tools, simplifying them for SMBs in a singular platform. Offering varied communication channels, appointment scheduling, payment processing, and more, enhances practitioner-patient relationships and optimizes practice operations. The company has a singular operating segment and revenue from subscription services.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.